BioImagene raises $26M in expansion capital

BioImagene, a leading provider of affordable digital pathology solutions for cancer diagnosis and preclinical research, today announced the closing of a $26 million series D financing round led by Burrill & Company.  Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.

Congratulations to Mohan Uttarwar and his team; that’s terrific.  Although we are competitors we are also friends, and we certainly want all the companies in our market to continue growing.  There is definitely enough market out there for all of us!